Φορτώνει......
The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
Proton pump inhibitors (PPIs) are the mainstay of therapy for all gastric acid related diseases and are commonly used in current clinical practice. Although widely regarded as safe, PPIs have been associated with a variety of adverse effects, including hypomagnesaemia. The postulated mechanism of PP...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J ASEAN Fed Endocr Soc |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Journal of the ASEAN Federation of Endocrine Societies
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784231/ https://ncbi.nlm.nih.gov/pubmed/33442177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15605/jafes.035.01.18 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|